Formation and Structure Clause Samples

The 'Formation and Structure' clause defines how a contract is created and organized between the parties. It typically outlines the steps required for the agreement to become legally binding, such as offer, acceptance, and consideration, and may specify the documents or components that make up the full contract, like schedules or appendices. By clearly establishing the process and framework for contract formation, this clause ensures that all parties understand when and how their obligations begin, reducing the risk of disputes over the validity or completeness of the agreement.
Formation and Structure. The Parties agree to form a Consortium structured and operated on the terms set forth in this Consortium Participation Agreement.
Formation and Structure. Each “Agreement” comprises the terms of this Subscription Agreement (“SA”) and each Order placed referencing its terms. Each Agreement entered into which refers to the terms of this SA constitutes a separate, standalone contract, which incorporates the terms of this SA and any amendments entered into between the Parties in writing. A reference in this SA to the “Agreement” means a reference to that Order only.
Formation and Structure. Each “Agreement” comprises the terms of this Subscription Agreement and each Order placed referencing its terms. Each Agreement entered into which refers to the terms of this Subscription Agreement constitutes a separate, standalone contract, which incorporates the terms of this Subscription Agreement and any amendments entered into between the Parties in writing. A reference in this Subscription Agreement to the “Agreement” means a reference to that Order only.
Formation and Structure. The Members have caused the Company to be formed as a limited liability company under the Act, for the purposes and upon the terms, covenants and conditions set forth in this Agreement.

Related to Formation and Structure

  • Formation and Name Office; Purpose; Term

  • Organization and Standing The Company is a corporation duly formed, validly existing and in good standing under the laws of the State of Delaware. The Company has all requisite power and authority to own and operate its properties and assets, to execute and deliver this Subscription Agreement, and any other agreements or instruments required hereunder. The Company is duly qualified and is authorized to do business and is in good standing as a foreign corporation in all jurisdictions in which the nature of its activities and of its properties (both owned and leased) makes such qualification necessary, except for those jurisdictions in which failure to do so would not have a material adverse effect on the Company or its business.

  • Formation and Purpose Promptly following the Effective Date, the Parties shall confer and then create the JSC and the IPC, and, optionally, create one or more of the other Committees listed in the chart below. Each Committee shall have the purpose indicated in the chart. To the extent that after conferring both Parties agree to not create a Committee (other than the JSC and the IPC), the creation of such Committee shall be deferred until one Party informs the other Party of its then desire to create the so-deferred Committee, at which point the Parties will thereafter promptly create the so-deferred Committee. Joint Steering Committee (“JSC”) Establish projects for the Bacteriophage Program and establish the priorities, as well as approve budgets for such projects. Approve all subcommittee projects and plans (except for decisions of the IPC). The JSC shall establish budgets not less than on a quarterly basis. Chemistry, Manufacturing and Controls Committee (“CMCC”) Establish project plans and review and approve activities and budgets for chemistry, manufacturing, and controls under the Bacteriophage Program. Regulatory Committee (“RC”) Review and approve all research and development plans and projects, including clinical projects, associated with any necessary regulatory approvals, all associated publications, and all regulatory filings and correspondence relating to gaining regulatory approval for new Ampliphi Products under the Bacteriophage Program; and review and approve itemized budgets with respect to the foregoing. Commercialization Committee (“CC”) Establish project plans and review and approve activities and budgets for Commercialization activities under the Bacteriophage Program. Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. Intellectual Property Committee (“IPC”) Evaluate all intellectual property issues in connection with the Bacteriophage Program; review and approve itemized budgets with respect to the foregoing.

  • Organization and Status Purchaser (a) is duly formed, validly existing and in good standing under the laws of the jurisdiction of its formation as set forth in the preamble to this Agreement, (b) is duly qualified, authorized to do business and in good standing in each other jurisdiction where the character of its properties or the nature of its activities makes such qualification necessary, and (c) has all requisite power and authority to own or hold under lease the property it purports to own or hold under lease and to carry on its business as now being conducted. Purchaser has made available to Seller complete and correct copies of the Organization Documents for Purchaser.

  • Organization and Existence Such Investor is a validly existing corporation, limited partnership or limited liability company and has all requisite corporate, partnership or limited liability company power and authority to invest in the Securities pursuant to this Agreement.